In the past decades, a great deal of research work has been devoted to the development of systems that could improve radiologists' accuracy in detecting lung nodules. Despite the great efforts, the problem is still open. In this paper, we present a fully automated system processing digital postero-anterior (PA) chest radiographs, that starts by producing an accurate segmentation of the lung field area. The segmented lung area includes even those parts of the lungs hidden behind the heart, the spine, and the diaphragm, which are usually excluded from the methods presented in the literature. This decision is motivated by the fact that lung nodules may be found also in these areas. The segmented area is processed with a simple multiscale method that enhances the visibility of the nodules, and an extraction scheme is then applied to select potential nodules. To reduce the high number of false positives extracted, cost-sensitive support vector machines (SVMs) are trained to recognize the true nodules. Different learning experiments were performed on two different data sets, created by means of feature selection, and employing Gaussian and polynomial SVMs trained with different parameters; the results are reported and compared. With the best SVM models, we obtain about 1.5 false positives per image (fp/image) when sensitivity is approximately equal to 0.71; this number increases to about 2.5 and 4 fp/image when sensitivity is = 0.78 and = 0.85, respectively. For the highest sensitivity (= 0.92 and 1.0), we get 7 or 8 fp/image.
MDCT has reasonable sensitivity in the detection of hepatocellular carcinoma in patients with cirrhosis who undergo liver transplantation. Attention should be paid, however, to avoiding overestimation of the extent of disease.
Purpose
The capability of lung ultrasound (LUS) to distinguish the different pulmonary patterns of COVID-19 and quantify the disease burden compared to chest CT is still unclear.
Methods
PCR-confirmed COVID-19 patients who underwent both LUS and chest CT at the Emergency Department were retrospectively analysed. In both modalities, twelve peripheral lung zones were identified and given a Severity Score basing on main lesion pattern. On CT scans the well-aerated lung volume (%WALV) was visually estimated.
Per-patient
and
per-zone
assessments of LUS classification performance taking CT findings as reference were performed, further revisioning the images in case of discordant results. Correlations between number of disease-positive lung zones, Severity Score and %WALV on both LUS and CT were assessed. The area under receiver operating characteristic curve (AUC) was calculated to determine LUS performance in detecting %WALV ≤ 70%.
Results
The study included 219 COVID-19 patients with abnormal chest CT. LUS correctly identified as positive 217 (99%) patients, but
per-zone
analysis showed sensitivity = 75% and specificity = 66%. The revision of the 121 (55%) cases with positive LUS and negative CT revealed COVID-compatible lesions in 42 (38%) CT scans. Number of disease-positive zones, Severity Score and %WALV between LUS and CT showed moderate correlations. The AUCs for LUS Severity Score and number of LUS-positive zones did not differ in detecting %WALV ≤ 70%.
Conclusion
LUS in COVID-19 is valuable for case identification but shows only moderate correlation with CT findings as for lesion patterns and severity quantification. The number of disease-positive lung zones in LUS alone was sufficient to discriminate relevant disease burden.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.